| INTRODUCTION
Amphotericin B is a potential anti-fungal antibiotic; it is a polyene and shows action on many species of fungi. It is mainly used in lifethreatening fungal infections and has evidence of producing nephrotoxicity when used in high doses; hence its use is limited. It also shows many dose-dependent adverse effects; allergic reactions, nausea and vomiting, and an imbalance in electrolytes are other adverse reactions. We report a case of development of acrocyanosis and increased serum creatinine levels on the use of amphotericin B. We describe the rare complications and evaluate the risk factors. Anisodamine was used to treat the acrocyanosis and pain.
| CASE REPORT
A 70-year-old man was admitted to hospital due to histoplasmosis. The patient's past medical history included senile degenerative valvular heart disease, alteration in ventricular contractions, and anemia.
He had not previously had any other pain, acrocyanosis, or allergies to food, drugs, or pollens. His personal history revealed alcohol and smoking habits for 40 years, which he had ceased 2 years previously.
He had experienced histoplasmosis previously and had been treated with itraconazole, voriconazole, and caspofungin acetate successfully a year previously; the oral solution of itraconazole had been prescribed on discharge 9 months previously. In the Pulmonology Department, the patient now reported week-long pain in the right back and chest side, respectively; he also reported that he had stopped taking the oral solution of itraconazole 3 months previously.
The vital signs of the patient are presented in Table 1 .
There was no wheezing and crackles were audible with both The patient was then admitted to the Pulmonology Department and he received intravenous (IV) cefepime 2 g for 12 hours in divided doses for the pulmonary infection. The treatment regimen also included IV mannitol 125 mL, oral alendronate sodium 70 mg once per week, and loxoprofen 60 mg twice a day. The same treatment regimen was followed to 8 days and the patient had no response to the regimen. On the 9th day, the patient complained that he had a severe pain on the right chest side. His CRP level was 157 mg/L; the loxoprofen was discontinued, and then IV tramadol was administered 0.1 g daily. A year previously, he had suffered from histoplasmosis, which was confirmed with biopsy on the right lung and scapula. As he was not responding to the cefepime, on the 12th day it was replaced with amphotericin B to treat the histoplas- ing is associated with Raynaud's phenomenon, 6 Buerger's disease, and impaired peripheral vasculature endothelium-dependent vasorelaxation, which might be a considerable risk factor. 7 Anisodamine is used for the treatment of acrocyanosis and pain; it has membrane stabilization and cell-protection action (which is probably related to its calcium antagonist action) and it reduces the serum creatinine level. 8 In conclusion, this case suggests that careful attention should be paid to amphotericin B-induced acrocyanosis and majorly elevated serum creatinine in elderly patients with a history of smoking and impaired renal function. Anisodamine was used to treat acrocyanosis and pain and the amphotericin B was discontinued.
The results need to be further confirmed in a large randomized controlled clinical trial, which is ongoing in our tertiary care teaching hospital.
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